TY - JOUR
T1 - Effect of upper respiratory tract infection in patients with neuromuscular disease
AU - Poponick, Janet M.
AU - Jacobs, I.
AU - Supinski, Gerald
AU - Dimarco, Anthony F.
PY - 1997
Y1 - 1997
N2 - Respiratory muscle strength during acute upper respiratory tract infection (URI) was assessed in patients with various forms of neuromuscular disease. Vital capacity (VC), oxygen saturation, end-tidal PCO2, maximal inspiratory pressure (MIP), and maximal expiratory pressure (MEP) were determined in 25 stable patients with various forms of neuromuscular disease. Thirteen episodes of URI developed in 10 patients. Respiratory parameters were reassessed within 24-36 h following the onset of symptoms in each patient. In patients with URI, mean baseline VC, MIP, and MEP were 1.16 L ± 0.14, 49.2 cm H2O ± 6.8, and 35.5 cm H2O ± 3.8 and fell to 1.01 L ± 0.15, 37.1 cm H2O ± 6.2, and 25.5 cm H2O ± 3.0 during URI (p < 0.05 for each), respectively. Mean baseline PCO2 and oxygen saturation were 39.1 mm Hg ± 1.1 and 95.1% ± 1.0, and during URI, 43.9 mm Hg ± 2.1 (p < 0.05) and 95.0% ± 1.0 (NS), respectively. Five episodes of significant hypercapnia were observed in 4 patients. All parameters returned to near baseline values following recovery. We conclude that patients with various forms of neuromuscular disease develop reductions in respiratory muscle strength in association with URI. Unlike normal subjects, however, these decrements in respiratory muscle function may result in symptoms of shortness of breath, reductions in vital capacity, and acute hypercapnia in this patient population.
AB - Respiratory muscle strength during acute upper respiratory tract infection (URI) was assessed in patients with various forms of neuromuscular disease. Vital capacity (VC), oxygen saturation, end-tidal PCO2, maximal inspiratory pressure (MIP), and maximal expiratory pressure (MEP) were determined in 25 stable patients with various forms of neuromuscular disease. Thirteen episodes of URI developed in 10 patients. Respiratory parameters were reassessed within 24-36 h following the onset of symptoms in each patient. In patients with URI, mean baseline VC, MIP, and MEP were 1.16 L ± 0.14, 49.2 cm H2O ± 6.8, and 35.5 cm H2O ± 3.8 and fell to 1.01 L ± 0.15, 37.1 cm H2O ± 6.2, and 25.5 cm H2O ± 3.0 during URI (p < 0.05 for each), respectively. Mean baseline PCO2 and oxygen saturation were 39.1 mm Hg ± 1.1 and 95.1% ± 1.0, and during URI, 43.9 mm Hg ± 2.1 (p < 0.05) and 95.0% ± 1.0 (NS), respectively. Five episodes of significant hypercapnia were observed in 4 patients. All parameters returned to near baseline values following recovery. We conclude that patients with various forms of neuromuscular disease develop reductions in respiratory muscle strength in association with URI. Unlike normal subjects, however, these decrements in respiratory muscle function may result in symptoms of shortness of breath, reductions in vital capacity, and acute hypercapnia in this patient population.
UR - http://www.scopus.com/inward/record.url?scp=0030791560&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030791560&partnerID=8YFLogxK
U2 - 10.1164/ajrccm.156.2.9611029
DO - 10.1164/ajrccm.156.2.9611029
M3 - Article
C2 - 9279255
AN - SCOPUS:0030791560
SN - 1073-449X
VL - 156
SP - 659
EP - 664
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 2 I
ER -